180 results on '"Brandl, Eva J."'
Search Results
2. Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study
3. Are Trained Medical Interpreters Worth the Cost? A Review of the Current Literature on Cost and Cost-Effectiveness
4. Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis
5. Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication
6. Multimodal neuroimaging measures and intelligence influence pedophile child sexual offense behavior
7. The influence of MIR137 on white matter fractional anisotropy and cortical surface area in individuals with familial risk for psychosis
8. Attitudes towards psychopharmacology and psychotherapy in psychiatric patients with and without migration background
9. Physicians' opinions following pharmacogenetic testing for psychotropic medication
10. Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies
11. No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gain
12. Association study between the neurexin‐1 gene and tardive dyskinesia
13. Trail Making Test Error Analysis in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer’s Dementia With and Without Depression
14. Genetic variation in CYP3A43 is associated with response to antipsychotic medication
15. Imaging Genetics of Working Memory
16. Trail Making Test Error Analysis in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Dementia With and Without Depression.
17. Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes
18. The Differential Impact of Lockdown Measures Upon Migrant and Female Psychiatric Patients – A Cross-Sectional Survey in a Psychiatric Hospital in Berlin, Germany
19. Pharmacogenetics of antidepressant treatment in obsessive–compulsive disorder: an update and implications for clinicians
20. Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain
21. The Differential Impact of Lockdown Measures Upon Migrant and Female Psychiatric Patients – A Cross-Sectional Survey in a Psychiatric Hospital in Berlin, Germany
22. Alcohol and Dementia – What is the Link? A Systematic Review
23. Additional file 1 of Attitudes towards psychopharmacology and psychotherapy in psychiatric patients with and without migration background
24. The influence of dopamine-related genes on perceptual stability
25. Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain
26. Pharmacogenetics of obsessive–compulsive disorders
27. 59 POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
28. Are Trained Medical Interpreters Worth the Cost? A Review of the Current Literature on Cost and Cost-Effectiveness
29. F51. Putative Causal Relationship Among Polygenic Scores, Cortical Surfaces, and General Intelligence
30. Psychische Symptombelastung bei Asylsuchenden in Abhängigkeit vom Aufenthaltsstatus
31. Psychische Erkrankungen bei Geflüchteten
32. Cortical Surfaces Mediate the Relationship Between Polygenic Scores for Intelligence and General Intelligence.
33. From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response
34. Cortical surface‐based threshold‐free cluster enhancement and cortexwise mediation
35. Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain
36. Psychische Symptombelastung bei Asylsuchenden in Abhängigkeit vom Aufenthaltsstatus.
37. Association of Dystrobrevin-Binding Protein 1 Polymorphisms with Sustained Attention and Set-Shifting in Schizophrenia Patients
38. Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain
39. Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes
40. Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain.
41. Klinische und soziodemografische Unterschiede zwischen Patienten mit und ohne Migrationshintergrund in einer Psychiatrischen Institutsambulanz.
42. Association of orexin receptor polymorphisms with antipsychotic-induced weight gain
43. Linking unfounded beliefs to genetic dopamine availability
44. Association Study of GABAA α2 Receptor Subunit Gene Variants in Antipsychotic-Associated Weight Gain
45. Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain.
46. Genetic variation in CYP3A43 is associated with response to antipsychotic medication
47. Poster #M135 A GENOME-WIDE ANALYSIS ON ANTIPSYCHOTIC-INDUCED WEIGHT GAIN USING REFINED CRITERIA IN THE CATIE SAMPLE
48. Investigation of melanocortin system gene variants in antipsychotic-induced weight gain
49. Pharmacogenetics of Antipsychotics
50. Fat Mass- and Obesity-Associated (FTO) Gene and Antipsychotic-Induced Weight Gain: An Association Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.